Clinical Trials Directory

Trials / Completed

CompletedNCT01626261

Examination of Implant´s Safety in an Electronic and Magnetic Field Environment

Study of Provocation Concerning Implants´Safety in Electronic and Magnetic Fields in Their Environment

Status
Completed
Phase
Study type
Observational
Enrollment
281 (actual)
Sponsor
RWTH Aachen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The number of active electrical cardiac implants such as internal cardioverter defibrillators (ICDs), pacemakers or cardiac contractility modules (CCM) has significantly risen over the last two decades. This has been paralleled by an increase in the number of sources of electromagnetic fields in daily life and occupational circumstances. To date it remains unclear whether patients are at risk of device failure when being subjected to these fields. There are currently no general guidelines available to help clinicians informing their patients about safety levels and behavior around these electromagnetic fields. This study aims to identify the thresholds of safe use of these devices and potential failures under worst-case conditions in 50/60 Hz fields (i.e. power line frequency). Device implanted patients will be exposed to electric, magnetic and combined fields of different intensity at various device programming (e.g. nominal and maximum sensitivity). The results will show whether patients are safe in public or occupational environments, which medical relevant disturbances can occur and if a correlation exists between disturbances and device type or patients physique.

Conditions

Interventions

TypeNameDescription
DEVICEMagnetic and electric field´s impact on the implantExamination of magnetic and electric field's impact on the implant regarding: stability detection threshold using different strength of magnetic and electric field

Timeline

Start date
2009-09-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2012-06-22
Last updated
2018-06-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01626261. Inclusion in this directory is not an endorsement.